The FDA has approved Abbott’s Tendyne system, the first transcatheter mitral valve replacement for patients with severe mitral annular calcification who are ineligible for open-heart surgery.
A global analysis finds JAK inhibitors significantly reduce COVID-19 deaths and ventilation needs in hospitalized patients, outperforming other therapies.
New research analyzing over 72,000 pregnant COVID-19 patients reveals they face a significantly reduced risk of developing long-term symptoms compared to nonpregnant women, with key risk factors identified across both cohorts.